FORMULATION AND ASSESSMENT OF GEMIFLOXACIN MESYLATE OCULAR IN SITU GELLING SYSTEM
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2013, Vol 4, Issue 10
Abstract
In situ gels are one of the most successful means of delivering the drug at ocular site with maximum bioavailability, which undergoes gelation upon instillation as drops into the eye due to physicochemical changes inherent to the biological fluids. The main aim of the present investigation was to obtain an ophthalmic drug delivery system with improved mucoadhesive and mechanical properties that could provide extended retention time for the treatment of ocular infections. For this in situ gels of Gemifloxacin Mesylate comprised of the combination of a thermosetting polymer, polaxamer with a mucoadhesive agent chitosan was developed. Fourier Transform Infrared Spectroscopy (FTIR) and Differential Scanning Calorimetry techniques (DSC) were performed to know the compatibilities between drug and polymer. FTIR spectra and DSC thermograph of Gemifloxacin Mesylate formulations showed that there is no chemical interaction between drug and polymer and confirmed the stability of the drug. The gels were evaluated for pH, Gel strength, Gelling capacity, Rheology, Drug content uniformity and Ocular irritancy studies. In vitro drug release studies reveal that all the formulations showed sustained release of the drug in the range of 70.82 to 76.43 % for a period of 8 h. The optimized formulation was tested for ocular irritation study on male albino rabbit and the result indicated that the formulation was well tolerated, non-irritating and therapeutically efficacious. In conclusion in situ gelling systems containing polaxamer / chitosan solution are viable alternative to enhance bioavailability thus leads to an excellent potential alternative ophthalmic sustained-release formulation of Gemifloxacin Mesylate in ocular infections.
Authors and Affiliations
Rajalakshmi R, Padmaja C, Radhika N, Kumuda P, Pavan P, Ujjwala B, Vinesha V.
Keywords
Related Articles
- EP ID EP131073
- DOI 10.7897/2230-8407.041009
- Views 86
- Downloads 0
CLINICAL EVALUATION OF KODIPAVALA CHUNNAM IN THE TREATMENT OF INFECTIVE HEPATITIS, DRUG INDUCED HEPATITIS AND ALCOHOLIC HEPATITIS
The present clinical study was carried out to validate the efficacy and safety of Siddha Herbo- mineral formulation ‘Kodipavala Chunnam’ in the treatment of Infective hepatitis, Drug induced hepatitis and Alcoholic hepat...
NANOTECHNOLOGY: A BOON OR BANE
Nanotechnology deals with the physical and chemical attributes of molecular scale structures, and they can be combined to form larger structures for human use. Because of this dimensional range, nanoparticles and structu...
CURCUMIN AND ITS PROMISING ROLE IN THE PREVENTION OF CANCER
Cancer is a disease in which cells grow abnormally in a group, uncontrollably deviating from the normal rules of cell division. It is regarded as the leading cause of death in economically developed countries and the sec...
REVIEW ON RECENT ADVANCES IN A MODERN DAY TREATMENT: DIURETIC THERAPY
The choice of drugs to initiate therapy for the management of hypertension remains contentious and diuretics are central to this controversy. Because most of the major trials involve complex treatment algorithms and allo...
NOVEL IN VITRO ANTIOXIDANT ESTIMATION OF PHENOLIC COMPOUNDS AND MOLECULAR MODELING STUDIES
A spectrophotometric method is carried out, for the first time, to estimate the antioxidant activity of phenolic compounds using DDQ assay. The method is based on the formation of a charge transfer complex (CTC) between...